enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Bladder cancer - Wikipedia

   en.wikipedia.org/wiki/Bladder_cancer

   Bladder cancer is most common in wealthier regions of the world, where exposure to certain carcinogens is highest. It is also common in places where schistosome infection is common, such as North Africa. [53] Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. [2]

3. Invasive urothelial carcinoma - Wikipedia

   en.wikipedia.org/wiki/Invasive_urothelial_carcinoma

   It is a type of cancer that develops in the urinary system: the kidney, urinary bladder, and accessory organs. Transitional cell carcinoma is the most common type of bladder cancer and cancer of the ureter, urethra, renal pelvis, the ureters, the bladder, and parts of the urethra and urachus.

4. Bristol Myers' Opdivo extends survival in bladder cancer study

   www.aol.com/news/bristol-myers-bladder-cancer...

   The drug met the dual main goals of extending overall survival and helping patients live without their disease worsening, in combination with chemotherapy followed by Opdivo, in the study testing ...

5. Urachal cancer - Wikipedia

   en.wikipedia.org/wiki/Urachal_cancer

   Urachal cancer can exist for some years without any symptoms. The most frequent initial symptom is haematuria which occurs when the urachal tumour has penetrated the bladder wall, but mucinuria (mucin in the urine), local pain or swelling, recurrent local or urinary tract infections and umbilical discharge can (but is not always) be seen.

6. Gilead's Trodelvy fails bladder cancer trial, modestly ... - AOL

   www.aol.com/news/gileads-trodelvy-extends-lung...

   (Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder cancer and only modestly extended the lives of previously treated patients with late-stage lung ...

7. Pfizer's bladder cancer therapy meets main goal in late-stage ...

   www.aol.com/news/pfizers-bladder-cancer-therapy...

   The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study in patients with high-risk non-muscle invasive bladder cancer (NMIBC ...